Overview
EXEL market data
Price History
EXEL price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for EXEL. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $53Benzinga · Jul 23, 2026, 6:03 PM
Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $49Benzinga · Jul 14, 2026, 11:03 AM
Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $49Benzinga · Jul 13, 2026, 2:25 PM
RBC Capital Maintains Sector Perform on Exelixis, Raises Price Target to $46Benzinga · Jul 7, 2026, 4:20 PM
Truist Securities Maintains Hold on Exelixis, Raises Price Target to $56Benzinga · Jul 7, 2026, 12:30 PM
UBS Maintains Neutral on Exelixis, Raises Price Target to $52Benzinga · Jul 2, 2026, 1:00 PM
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For ThursdayBenzinga · Jun 25, 2026, 2:20 PM
Truist Securities Downgrades Exelixis to Hold, Raises Price Target to $54Benzinga · Jun 25, 2026, 2:15 PM
Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $55Benzinga · Jun 24, 2026, 1:05 PM
Exelixis Provides 'A Highly Defensive Investment Profile:' AnalystBenzinga · Jun 22, 2026, 5:40 PM